论文部分内容阅读
应用免疫活性淋巴细胞作过继性免疫治疗(adop-tive immunotherapy)为临床治疗脑胶质瘤开辟了一条崭新的途径。继对 LAK 细胞(lymphokine-activatedkiller)的研究和临床试用性治疗脑胶质瘤之后,又发展到对第二代抗肿瘤效应细胞-TIL(tumor-infiltratinglymphocytes)的研究。随着免疫生物学的发展和免疫
The application of immunocompetent lymphocytes as a adoptive immunotherapy has opened a new avenue for clinical treatment of glioma. Following the study of LAK cells (lymphokine-activatedkiller) and clinical trial of treatment of glioma, the second generation of tumor-infiltrating lymphocytes was also developed. With the development of immune biology and immunity